This HTML5 document contains 179 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
n11http://dx.doi.org/10.1634/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q35863880
rdf:type
wikibase:Item
schema:description
2012年论文 article scientifique artigo científico teaduslik artikkel wissenschaftlicher Artikel мақолаи илмӣ mokslinis straipsnis 2012年論文 artikel ilmiah vědecký článek 2012年论文 artikulong pang-agham videnskabelig artikel artículo científico publicado en 2012 artykuł naukowy scienca artikolo 2012 nî lūn-bûn naučni članak 2012년 논문 artículu científicu espublizáu en 2012 bilimsel makale наукова стаття, опублікована в лютому 2012 ২০১২-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 2012年論文 2012年论文 artigo científico scientific article published on 14 February 2012 مقالة علمية نشرت بتاريخ 14-2-2012 գիտական հոդված vedecký článok wetenschappelijk artikel article scientific 2012年論文 სამეცნიერო სტატია vitenskapelig artikkel scientific article published on 14 February 2012 научная статья 2012年论文 artikull shkencor articol științific 2012年論文 vitskapeleg artikkel 2012年论文 bài báo khoa học научни чланак 2012年论文 научни чланак vetenskaplig artikel мақолаи илмӣ tudományos cikk article científic 2012年の論文 מאמר מדעי artigo científico articolo scientifico บทความทางวิทยาศาสตร์ 2012年論文 scientific article published on 14 February 2012 научна статия tieteellinen artikkeli επιστημονικό άρθρο
p:P577
wds:Q35863880-7061B36A-3E33-4E8B-8548-0DA757DBB171
wdt:P577
2012-02-14T00:00:00Z
p:P2860
wds:Q35863880-A02DB0F1-AFF5-4D38-A1E1-369847042ABC wds:Q35863880-A4D235B2-4867-4B5C-B321-B9EF1EF280A5 wds:Q35863880-B051FC85-9A6B-4CEE-9BA9-2D45796AE133 wds:Q35863880-B4ED5C40-2039-497D-BF0A-B2D079CF87D0 wds:Q35863880-BBD10BF4-BDE0-40C0-9A09-5AB14972B411 wds:Q35863880-C60E23B5-EAFB-442A-AECF-B8185F62B325 wds:Q35863880-7AE6B2AA-2C16-4A89-A856-419F0A2702DF wds:Q35863880-7CD3AC73-DE1F-4C2A-9D95-BE7B86FDAE6C wds:Q35863880-87FC50EC-919B-47BD-BF9F-A8E2D577D994 wds:Q35863880-959FCBC7-D628-4422-BAA5-251870BC700E wds:Q35863880-9FF5D2D5-AF69-4159-9E82-9E4FF9474671 wds:Q35863880-452C1343-5677-4233-874B-DBB430FB4E37 wds:Q35863880-4CAEF798-80A8-4A3C-94A9-D24B53B608CF wds:Q35863880-509AA77A-A81C-4C60-BD1C-D0A1CF0DDEA6 wds:Q35863880-568AD6AF-C033-4093-8391-3F5B2155AB3D wds:Q35863880-653AEDE1-702C-478B-BCBC-4ECAAF68AED8 wds:Q35863880-37E5A837-1C0D-459F-A5D7-EDECCA9916CE wds:Q35863880-384F4AD9-7BAD-449C-B92F-79F672E1A5A1 wds:Q35863880-3EC49E89-C675-4DE4-886C-F1AD9000B47F wds:Q35863880-4072A031-CB90-4CDC-8A07-98307606C922 wds:Q35863880-410EC177-43BA-4326-88DC-1AAECFDFBE7E wds:Q35863880-42738EE3-8BEB-4032-B0C9-E4DBD618F89C wds:Q35863880-0CBC7872-BBA6-4353-AB33-F470FE46F1A7 wds:Q35863880-10F67D0B-8318-4622-9055-AB2B02A7A097 wds:Q35863880-151C214C-BC14-4FCB-876A-C9D5E812950C wds:Q35863880-2937C05F-9F36-46B4-9F16-834254759BC1 wds:Q35863880-2F069D71-CCB7-4995-B8C4-B4D0340C0BBD wds:Q35863880-F6955F74-ABFD-4035-9492-336D2787413A wds:Q35863880-F75CCBAD-6438-4BC8-8794-9FCF19D8C552 wds:Q35863880-F779F281-F5EB-4E63-9C8A-8459112C1E41 wds:Q35863880-D4EAA5F9-2DAD-4AC4-A277-C5716C93BF3C wds:Q35863880-D677A497-3C05-4FB3-950E-DCC3EAB181FB wds:Q35863880-DC900024-84C2-4021-BB33-67232A67384C wds:Q35863880-EB57A8A5-A430-433A-B640-B5D2766604DB wds:Q35863880-F06B5FA6-1F0D-4658-86E9-A63680DF5020
wdt:P2860
wd:Q74212232 wd:Q40198053 wd:Q79294727 wd:Q29617585 wd:Q29547903 wd:Q34347862 wd:Q53180954 wd:Q79152291 wd:Q34552214 wd:Q35193958 wd:Q37832102 wd:Q27861075 wd:Q37825177 wd:Q28383646 wd:Q42983661 wd:Q35929224 wd:Q73340869 wd:Q29615765 wd:Q33728605 wd:Q28306363 wd:Q37813315 wd:Q37253389 wd:Q36812745 wd:Q34163359 wd:Q35929156 wd:Q69351199 wd:Q53523823 wd:Q33392573 wd:Q36596834 wd:Q37736238 wd:Q28247867 wd:Q37316980 wd:Q39871560 wd:Q46821572 wd:Q43645553
p:P2093
wds:Q35863880-F88C16D3-A00D-46E5-AA66-59D1F9A792BF wds:Q35863880-6AE642DD-04DB-4D2B-A991-79F6D80C0758
wdt:P2093
Franco Dammacco Domenico Sansonno
rdfs:label
Transarterial chemoembolization plus sorafenib: a sequential therapeutic scheme for HCV-related intermediate-stage hepatocellular carcinoma: a randomized clinical trial. Transarterial chemoembolization plus sorafenib: a sequential therapeutic scheme for HCV-related intermediate-stage hepatocellular carcinoma: a randomized clinical trial. Transarterial chemoembolization plus sorafenib: a sequential therapeutic scheme for HCV-related intermediate-stage hepatocellular carcinoma: a randomized clinical trial.
skos:prefLabel
Transarterial chemoembolization plus sorafenib: a sequential therapeutic scheme for HCV-related intermediate-stage hepatocellular carcinoma: a randomized clinical trial. Transarterial chemoembolization plus sorafenib: a sequential therapeutic scheme for HCV-related intermediate-stage hepatocellular carcinoma: a randomized clinical trial. Transarterial chemoembolization plus sorafenib: a sequential therapeutic scheme for HCV-related intermediate-stage hepatocellular carcinoma: a randomized clinical trial.
schema:name
Transarterial chemoembolization plus sorafenib: a sequential therapeutic scheme for HCV-related intermediate-stage hepatocellular carcinoma: a randomized clinical trial. Transarterial chemoembolization plus sorafenib: a sequential therapeutic scheme for HCV-related intermediate-stage hepatocellular carcinoma: a randomized clinical trial. Transarterial chemoembolization plus sorafenib: a sequential therapeutic scheme for HCV-related intermediate-stage hepatocellular carcinoma: a randomized clinical trial.
p:P50
wds:Q35863880-3036DD01-9877-413F-ADD5-655756152999 wds:Q35863880-8C611AC4-79CF-4E65-A8C8-5852143FE48F wds:Q35863880-B89483CE-F36B-424D-BD2A-8B2702C2854A wds:Q35863880-CC6809DD-35F6-4391-BEC3-1CF555100C17
wdt:P50
wd:Q117519220 wd:Q64495656 wd:Q38326899 wd:Q56761615
p:P1476
wds:Q35863880-03453232-B5B0-4D65-8BA2-0AF7B0B98CD6
wdt:P1476
Transarterial chemoembolization plus sorafenib: a sequential therapeutic scheme for HCV-related intermediate-stage hepatocellular carcinoma: a randomized clinical trial
p:P304
wds:Q35863880-1096E230-D6DC-4745-867C-11D24439569A
wdt:P304
359-366
p:P31
wds:Q35863880-83974CD1-2BD2-4E60-A084-3B6DF3EDCA45
wdt:P31
wd:Q13442814
p:P921
wds:Q35863880-88FD99C5-1D39-48B2-9C5F-C8C0EEA79AE6
wdt:P921
wd:Q1148337
p:P698
wds:Q35863880-3D7A4542-2A70-44CA-AF48-882A2E8299FA
wdtn:P698
n12:22334456
wdt:P698
22334456
p:P1433
wds:Q35863880-06C9ED6B-A0E9-4F2C-A11B-6DB755224541
wdt:P1433
wd:Q2122327
p:P433
wds:Q35863880-CFCE37F1-1790-4446-AE71-5693B469F253
p:P478
wds:Q35863880-E410572F-9292-4806-AE54-87BDF3CCB838
wdt:P433
3
wdt:P478
17
p:P356
wds:Q35863880-5808C39A-6972-42E6-9E4A-8DABCE3CA95B
wdtn:P356
n11:THEONCOLOGIST.2011-0313
wdt:P356
10.1634/THEONCOLOGIST.2011-0313
p:P5875
wds:Q35863880-F9C39439-A4B6-4458-8904-8E86BDFD79F3
wdt:P5875
221832488
p:P932
wds:Q35863880-DA7B4E6E-8696-4DE5-94F5-00723380A20A
wdt:P932
3316921